LY 311727
Chemical Name: [3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonic acid
Purity: ≥97%
Biological Activity
Selective secreted phospholipase A2 (sPLA2) inhibitor (IC50 values are <1 μM for group IIA and <50 μM for group V). Attenuates VEGF-mediated platelet-activating factor (PAF) synthesis in BAEC and HUVEC cells at a concentration of 100 μM.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.
Schevitz et al.
Nat.Struct.Biol., 1995;2:429 -
VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2.
Bernatchez et al.
Br.J.Pharmacol., 2001;134:197 -
High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
Bridonneau et al.
J.Med.Chem, 1997;41:778
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for LY 311727
The citations listed below are publications that use Tocris products. Selected citations for LY 311727 include:
1 Citation: Showing 1 - 1
-
Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
Authors: Mock Et al.
Integr Biol (Camb) 2013;5:172
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for LY 311727
There are currently no reviews for this product. Be the first to review LY 311727 and earn rewards!
Have you used LY 311727?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
